Michael P. Czech,Aimee Powelka,Adilson L. Guilherme,Andrew D. Cherniack
申请号：
US13345390
公开号：
US20120208862A1
申请日:
2012.01.06
申请国别(地区):
US
年份:
2012
代理人:
摘要：
Inhibition of RIP140 increases glucose transport. Compounds that inhibit RIP140 expression or activity are useful for treating disorders associated with aberrant glucose transport (e.g., diabetes), treating obesity, increasing metabolism (e.g., fatty acid metabolism), and increasing brown fat.
